To investigate whether the breakpoint of SLC45A2-AMACR is targetable by Cas9-mediated insertion of HSV1-tk, a pair of gRNA was designed to direct the cutting in the breakpoint region of the cancer genome by Cas9. The gene discussed is SLC45A2; the disease is cancer.